To investigate the molecular mechanisms of photoreceptor-specific gene transcription, we examined the role of the neuronal-enriched Sp4 nuclear protein in transcription from the rod-specific ␤-PDE and rod opsin gene promoters and compared it to the ubiquitous members of the Sp family, Sp1 and Sp3. Sp4 activates both the rod opsin and ␤-PDE promoters, whereas Sp1 activates only the rod opsin promoter and Sp3 activates neither promoter. Interestingly, Sp1 and Sp3 competitively repress Sp4-mediated activation of the ␤-PDE promoter. In addition, Sp4, Sp1, and Sp3 each show functional synergy with the photoreceptor-enriched Crx transcriptional regulator on the rod opsin promoter but not the ␤-PDE promoter, although Sp4-mediated activation was the most significant. Sp4, Sp1, and Sp3 bind Crx in co-immunoprecipitation experiments, and their zinc finger domains as well as the Crx homedomain are necessary and sufficient for these interactions. Chromatin immunoprecipitation showed that the rod opsin and ␤-PDE promoters are targets of both Sp4 and Crx, which further supports Sp4-Crx interactions in vivo in the context of retinal chromatin environment. In situ hybridization and immunohistochemistry demonstrated that Sp4 is abundantly expressed in various neurons of all retinal layers, and thus co-localizes or overlaps with multiple retina-restricted and -enriched genes, its putative targets. Our results indicate that photoreceptorspecific gene transcription is controlled by the combinatorial action of Sp4 and Crx. The other Sp family members may be involved in photoreceptor-specific transcription directly or through their competition with Sp4. These data suggest the potential importance of Sp4 in retinal neurobiology and pathology.
To investigate the molecular mechanisms of photoreceptor-specific gene transcription, we examined the role of the neuronal-enriched Sp4 nuclear protein in transcription from the rod-specific ␤-PDE and rod opsin gene promoters and compared it to the ubiquitous members of the Sp family, Sp1 and Sp3. Sp4 activates both the rod opsin and ␤-PDE promoters, whereas Sp1 activates only the rod opsin promoter and Sp3 activates neither promoter. Interestingly, Sp1 and Sp3 competitively repress Sp4-mediated activation of the ␤-PDE promoter. In addition, Sp4, Sp1, and Sp3 each show functional synergy with the photoreceptor-enriched Crx transcriptional regulator on the rod opsin promoter but not the ␤-PDE promoter, although Sp4-mediated activation was the most significant. Sp4, Sp1, and Sp3 bind Crx in co-immunoprecipitation experiments, and their zinc finger domains as well as the Crx homedomain are necessary and sufficient for these interactions. Chromatin immunoprecipitation showed that the rod opsin and ␤-PDE promoters are targets of both Sp4 and Crx, which further supports Sp4-Crx interactions in vivo in the context of retinal chromatin environment. In situ hybridization and immunohistochemistry demonstrated that Sp4 is abundantly expressed in various neurons of all retinal layers, and thus co-localizes or overlaps with multiple retina-restricted and -enriched genes, its putative targets. Our results indicate that photoreceptorspecific gene transcription is controlled by the combinatorial action of Sp4 and Crx. The other Sp family members may be involved in photoreceptor-specific transcription directly or through their competition with Sp4. These data suggest the potential importance of Sp4 in retinal neurobiology and pathology.
Phototransduction, the conversion of light into a neural signal, occurs in rod and cone photoreceptors of mammalian retina and is essential for vision (1) . In rods, light is absorbed by the transmembrane visual pigment, rhodopsin. This triggers a complex cascade of biochemical events leading to the activation of the ␣ and ␤ catalytic subunits of rod-specific cGMP-phosphodiesterase (PDE), 1 which results in cGMP hydrolysis and closure of ion channels in the photoreceptor plasma membrane. Genetic defects in various components of the phototransduction cascade lead to retinal pathology. Mutations in the ␤-subunit of PDE (␤-PDE) gene cause retinal degeneration in the rd mouse and Irish Setter dog, as well as autosomal recessive retinitis pigmentosa in human (2) (3) (4) . Rod opsin gene mutations are the most common cause of autosomal dominant retinitis pigmentosa (5, 6) .
Because of the paramount role of the phototransduction cascade in photoreceptor neurobiology, an understanding of the molecular events that control transcription of its various components is of great importance. We have previously defined the minimal rod-specific promoter in the ␤-PDE gene (Ϫ93/ϩ53) necessary and sufficient for directing high levels of rod-specific transcription in vitro and ex vivo, which was further confirmed in vivo by the generation of transgenic Xenopus expressing different ␤-PDE promoter/GFP fusion constructs (7) . In addition, we identified a GC-rich regulatory element (␤/GC) necessary for high-level transcription from the ␤-PDE promoter. Although several Sp transcription factors were shown to bind the ␤/GC element in vitro, only the central nervous system-and retina-enriched Sp4 significantly enhanced ␤-PDE promoter activity.
Another transcription factor crucial for the regulation of several photoreceptor-specific genes is Crx (8 -10) . It is an otd/Otx-like homeodomain transcription factor expressed predominantly in rod and cone photoreceptors, and in certain other retinal neurons. Crx is essential for the development and maintenance of photoreceptors (11, 12) . Mutations in CRX have been associated with various forms of retinal degeneration including autosomal dominant cone-rod dystrophy, Leber congenital amaurosis, and retinitis pigmentosa (13) (14) (15) (16) .
In this paper, we show that Sp4 is expressed in photoreceptors and other retinal neurons, and is a potent activator of transcription of the rod-specific ␤-PDE and rod opsin genes. Sp3 and possibly Sp1 may inhibit Sp4-mediated transcriptional activation of the ␤-PDE promoter presumably by direct competition for DNA binding. Crx directly binds Sp4, Sp1, and Sp3, and activates transcription from the rod opsin promoter synergistically with each of these Sp proteins, although the greatest effect is seen with Sp4. Crx and Sp4 co-occupy promoters of rod opsin and ␤-PDE genes, which strongly supports their putative interactions in vivo. These results thus suggest an important role for Sp4 and perhaps certain other Sp transcriptional regulators in the combinatorial control of photoreceptor-specific gene expression.
EXPERIMENTAL PROCEDURES
Plasmid Constructs-The reporter constructs employed in our studies contain previously characterized minimal rod photoreceptor-specific promoters for the ␤-PDE and rod opsin genes. The ␤-PDE/luc construct has the Ϫ93/ϩ53 region of human ␤-PDE promoter (7) . The Rho/luc construct contains the Ϫ130/ϩ70 region of the bovine rod opsin promoter (8) . The pRC/CMV-Sp4 construct contains the full-length Sp4 cDNA, the pRC/CMV-Sp1 construct the full-length Sp1 cDNA, and the pRC/CMV-Sp3 construct, the full-length Sp3 cDNA. These constructs as well as their deletion mutants pRC/CMV-Sp4⌬DBD (containing the N-terminal portion of Sp4 from amino acid 1 to 620 with its zinc finger DNA-binding domain deleted), pCITE4b-Sp4ZnD, pCITE4b-Sp3ZnD, and pET3b-Sp1ZnD (each encoding a C-terminal portion of the respective Sp protein containing the zinc finger DNA binding domain) were kindly provided by Drs. Guntram Suske and Man-Wook Hur (17) (18) (19) . pCITE4b-Sp4ZnD encodes the truncated Sp4 peptide from amino acid 616 to 784; pCITE4b-Sp3ZnD, the truncated Sp3 peptide from amino acid 501 to 697; and pET3b-Sp1ZnD, the truncated Sp1 peptide from amino acid 610 to 778. The constructs containing bovine Crx cDNA, CrxWT (encoding full-length Crx), Crx⌬HD (encoding amino acids 111-299), and CrxHD (encoding amino acids 1-107) in the mammalian expression vector pcDNA3.1/HisC (Invitrogen) were described previously (20) .
Cell Cultures and Transient Transfections-Human embryonic kidney 293 (HEK293) cells were obtained from the American Type Culture Collection (Manassas, VA), and were propagated in Dulbecco's modified Eagle's medium/F-12 (Invitrogen) supplemented with 10% fetal calf serum. These cells have been used extensively for testing multiple retina-specific promoters including that of the ␤-PDE gene as well as retina-relevant transcription factors including Sp4 and Crx (7, 8, 21, 22) . Y79 retinoblastoma cells were cultured in RPMI 1640 (Invitrogen) supplemented with 15% (v/v) fetal calf serum (Invitrogen) as described previously (23) .
Calcium phosphate-mediated transient transfections as well as luciferase and ␤-galactosidase assays were performed as previously described (22, 23) . For normalization of transfection efficiency, all transfection reactions included 5 g of the pSV-␤-galactosidase expression plasmid as an internal control. We have characterized the use of this vector for transfection efficiency control with Sp proteins in HEK293 cells previously (22) , and have not seen significant differences in ␤-galactosidase activity in raw data in the current studies. In co-transfection experiments, the ratios of the reporter vector to expression plasmid were determined empirically based on our previous data (7, 21, 22) . For each experiment, the total amount of transfected DNA per plate was kept constant by adding empty plasmid DNA. Triplicate plates were used for all transfections, and experiments were repeated several times.
In Vitro Translation and Co-immunoprecipitation-35 S-Labeled and unlabeled recombinant Crx and the Sp proteins were generated from 2 g of DNA using the TNT T7 Quick coupled Transcription/Translation System (Promega) in the presence or absence of L-[
35 S]methionine (ICN Biochemicals). Co-immunoprecipitation assays were carried out essentially as described (24) . Anti-Sp4 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and described previously (22) . The anti-Crx antibody, P261, has been described previously (24) .
Chromatin Immunoprecipitation-Chromatin immunoprecipitation (ChIP) assays using adult mouse retinas and liver tissue were performed as previously described (25) . Briefly, retinas (n ϭ 6 -8) or liver (30 mg) were collected from adult wild-type C57BL/6 mice. Chromatinbinding proteins were cross-linked by treating the tissue with 1% formaldehyde in PBS for 15 min at room temperature. Tissues were disaggregated in cold 1ϫ PBS using a Dounce homogenizer, and cells were lysed in Cell Lysis Buffer (5 mM PIPES, pH 8.0, 85 mM KCl, 0.5% Nonidet P-40 plus a mixture of proteinase inhibitors (Roche)) for 15 min at 4°C. Nuclei were collected at 4°C by centrifugation at 5,000 ϫ g for 5 min and lysed in Nuclear Lysis Buffer (50 mM Tris-Cl, pH 8.1, 10 mM EDTA, 1% SDS with protease inhibitors) for 15 min. The chromatin was fragmented by sonication to an average length of ϳ600 bp. The chromatin suspension was precleared using Protein-A beads (Amersham Biosciences), and then incubated with 1 g of an antibody specific to Crx or Sp4 at 4°C overnight. Normal rabbit IgG (Santa Cruz) was used as a negative control. Protein-A beads were added to the samples and incubated for 15 min at 4°C. The beads were collected by centrifugation at 10,000 ϫ g for 3 min and washed once in Wash Buffer I (0.1% SDS,1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.0), four times in Wash Buffer II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 500 mM NaCl, 20 mM Tris-HCl, pH 8.0), once in Wash Buffer III (250 mM LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0), and once in 1ϫ TE (10 mM Tris-HCl, pH 8.0, 10 mM EDTA) at room temperature for 10 min each. The protein-DNA complexes were then eluted from the beads using Elution Buffer (50 mM NaHCO 3 , 1% SDS), and the cross-links were removed by heating at 67°C for 4 -5 h. DNA was purified from the complexes by phenol/chloroform extraction and ethanol precipitation, and analyzed by PCR using gene-specific primers as described previously (25) .
In Situ Hybridization-In situ hybridization was performed essentially as previously described (26) . The eyes were obtained from 2-month-old C57BL/6 mice, fixed in 4% paraformaldehyde in PBS, pH 7.4, at 4°C overnight, cryoprotected in 30% sucrose in PBS, embedded for sagittal sectioning in pre-chilled O.C.T. compound, frozen on dry ice, and cryosectioned at 10 m through the central retina. Slides were allowed to dry overnight. Additional fixation was performed before the hybridization procedure in 4% paraformaldehyde in PBS, pH 7.4, for 15 min at room temperature. The riboprobes were generated from the pCRII-TOPO plasmid (Invitrogen), into which Sp4 cDNAs were subcloned and sequenced to ensure the proper orientation. Various sized fragments of the mouse Sp4 cDNA were used for the generation of three different probes. KGH-1 (1588 bp) was: forward primer: Sp4/ms1 (exon 1), 5Ј-ccccacccacctctatcccagtgt-3Ј; reverse primer, Sp4/ma1 (exon 4), 5Ј-cacaggagcaatctgagcaac-3Ј; KGH-2 (776 bp), forward primer, Sp4/ms2 (exon 4), 5Ј-gcagcagcctttgcagaa-3Ј; reverse primer, Sp4/ma2 (exon 5), 5Ј-ctctgaagctcatcgctcctt-3Ј; KGH-3 (222 bp), forward primer, Sp4/ms3 (exon 5), 5Ј-ttgcctgctcctgtcctaact-3Ј; reverse primer, Sp4/ma3 (exon 6), 5Ј-tctctgaagctcatcgctcct-3Ј. The plasmids were linearized either with HindIII for transcription from the T7 promoter (for antisense probes), or by XhoI for transcription from the Sp6 promoter (for sense probes). Linearized plasmids were utilized for in vitro transcription with either Sp6 RNA polymerase (antisense probe) or T7 RNA polymerase (sense probe) in the presence of digoxigenin RNA labeling mixture (Roche Applied Science). The probes were diluted to the final concentration of 3 ng/l and used for hybridization overnight at 65°C in a humidified chamber. Immunodetection was carried out overnight using a 1:2000 dilution of alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche). For the visualization of hybrids, nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate chromogenic substrate was used (Roche).
Immunohistochemistry-Immunohistochemistry was carried out essentially as previously described (27) . The eyes from adult wild-type C57BL/6 mice were fixed overnight in 10% formalin/PBS, pH 7.4, and processed for paraffin embedding. Following heat-induced epitope retrieval, retinal tissue sections were probed with rabbit anti-Sp4 antibodies that target the C terminus of Sp4 (V-20, Santa Cruz Biotechnology) at a 1:800 dilution (determined empirically), and hematoxylin was used for counterstaining cell nuclei. We had previously characterized this anti-Sp4 antibody by immunoblotting mouse whole retinal nuclear extract and observed a single major band of predicted molecular mass of 95-105 kDa (7). Specific Sp4 labeling was visualized using 3,3Ј-diaminobenzidine peroxidase substrate (Sigma). Stained sections were examined by light microscopy and photographed at ϫ400 magnification. We also used another anti-Sp4 antibody that targets the N terminus of Sp4 (H-270, Santa Cruz Biotechnology), which produced an identical staining pattern to that observed with the V-20 antibody. As negative control, the primary anti-Sp4 antibody was omitted from the staining procedure.
RESULTS

Promoters of the Rod-Specific ␤-PDE and Rod opsin Genes
Are Differentially Activated by Sp4, Sp1, and Sp3-We previously characterized the minimal rod-specific ␤-PDE promoter and showed that it contains a potent regulatory element that binds members of the Sp family of the transcriptional regulator and is activated by Sp4 (7, 22) . Therefore, we hypothesized a more general role for Sp4 in transcriptional regulation of photoreceptor-enriched genes and particularly those expressed in rods such as the rod-specific rod opsin gene. Initially, we tested the Sp4 transactivation potential on the rod opsin and ␤-PDE gene promoters utilizing transient co-transfections of Y79 human retinoblastoma cells. However, only minimal transactivation was observed (not shown), which was attributed to the very low transfection efficiency in Y79 retinoblastoma cells (less than 1%) combined with high levels of endogenous retinaenriched nuclear proteins (7, 28) . 2 Thus, we compared the rod-specific opsin and ␤-PDE promoters for their ability to direct luciferase expression in non-retinal HEK293 cells that have a much higher transfection potential than Y79 retinoblastoma cells. Although luciferase activity differed between the two reporter constructs tested, both promoters showed high enough activity well above the empty pGL2-basic vector and within the range suitable for further evaluation in co-transfection experiments (Fig. 1A) . We then tested whether Sp4 was able to regulate transcription from these rod-specific promoters in co-transfections of HEK293 cells. Equal amounts of the Sp4 expression plasmid were cotransfected with each promoter-containing reporter plasmid and luciferase activity was compared with that of the respective unstimulated reporter. Substantial Sp4-mediated transcriptional activation was observed on both of these rod-specific promoters (Fig. 1, B and C) .
Next, we asked whether such a potent activator effect was unique to Sp4. To investigate this, we compared the Sp4 results to those obtained using another common member of the Sp family, Sp1. Consistent with our previous results, only minimal Sp1-mediated activation was observed on the ␤-PDE promoter (Fig. 1B) . However, substantial transcriptional activation (approximately17-fold) was noted using Sp1 on the rod opsin promoter (Fig. 1C) .
To further test the specificity of Sp4-mediated transactivation of these rod-specific promoters, co-transfections were carried out using the ␤-PDE and rod opsin reporter constructs with another member of the Sp family, Sp3, that has similar DNA-binding properties as Sp4 and Sp1 (17) . We observed that Sp3 completely lacks any substantial activation potential on either of the tested promoters (Fig. 1, B and C) . These data are corroborated by the studies on non-neuronal promoters showing that Sp3 functions primarily as an inhibitory transcriptional regulator (17, 29) . Thus, our results suggest that Sp4 and Sp1, but not Sp3, can differentially enhance promoter activity of certain rod-enriched genes.
Sp1 and Sp3 Do Not Superactivate but Competitively Inhibit Sp4-mediated Activation of the ␤-PDE Promoter-We hypothesized that Sp1 and Sp3 may repress Sp4-mediated transcriptional activation on certain photoreceptor-specific promoters if present in sufficiently high quantities. This hypothesis was based on the results described above that Sp1 and Sp3 (unlike Sp4) are not able to activate certain retina-specific genes, but have identical DNA binding affinity and specificity as Sp4 (17) . However, it is also possible that these structurally related Sp proteins might be involved in protein-protein interactions with each other resulting in superactivation of the target promoter even if one of the proteins lacks a strong activation domain. To test this hypothesis, we co-transfected a constant amount of the Sp4 expression construct (1.0 g) with the reporter plasmid containing the ␤-PDE promoter, along with increasing amounts of either Sp1 or Sp3 expression construct. The results show that Sp4-mediated transactivation of the ␤-PDE promoter was repressed by either Sp1 or Sp3 in a dose-dependent manner (Fig. 2) .
As additional control, 3 g of the Sp4 expression plasmid were co-transfected with the ␤-PDE promoter-reporter plasmid and showed no additional increase in promoter activation compared with 1 g of the Sp4, which suggests a saturation effect consistent with our previous observation, but needs more extensive testing (22) . However, 3 g of the Sp4 construct showed a much higher luciferase activity than 3 g of the mixture of the Sp4 construct (1.0 g) with either Sp1 (2.0 g) or Sp3 A, comparison of activities of the rod-specific ␤-PDE and rod opsin promoters in HEK293 cells. 2 g of the ␤-PDE/luc or Rho/luc reporter plasmid were transiently transfected in HEK293 cells and the relative luciferase activities were compared with that of the empty pGL2-basic vector, and expressed as percent of the ␤-PDE/luc mean activity Ϯ S.D. B, the ␤-PDE/luc reporter construct (2 g) was co-transfected in HEK293 cells with expression constructs (pRC/CMV-Sp1, pRC/CMV-Sp3, and pRC/CMV-Sp4; 2 g of each plasmid) encoding different members of the Sp family (see "Experimental Procedures"). C, same as in B except that the Rho/luc construct was co-transfected with different Sp expression constructs (2 g of each plasmid) encoding different members of the Sp family. Relative luciferase activities were compared with those produced by each respective unstimulated promoter co-transfected with a control empty plasmid and expressed as -fold induction of the mean activity Ϯ S.D. Luciferase activity was measured in cell lysates and normalized for each sample as described under "Experimental Procedures." Each transfection was done in triplicate and repeated at least twice. expression construct (2.0 g). Recently, we showed that Sp4 and Sp1 bind the same ␤/GC response element within the ␤-PDE proximal promoter consistent with their previously reported identical DNA binding specificity and affinity at the consensus GC-or GT-box elements tested (7, 17) . Thus, the repression of Sp4-activated ␤-PDE transcription by either Sp1 or Sp3 is likely because of the competition of these proteins for their common DNA recognition sequence.
Sp4 Functionally Synergizes with Crx on the Rod opsin Promoter but Not on the ␤-PDE Promoter; Sp1 and Sp3 also Synergize with Crx-To investigate the combinatorial mechanisms of transcriptional regulation of photoreceptor-enriched genes, we asked whether Sp4 interacts with another transcriptional regulator, Crx that regulates rod opsin and multiple other photoreceptor-specific or -enriched genes, and is crucial for photoreceptor development and maintenance of the adult retinal phenotype (8, 10 ). Thus, we tested whether co-expression of Sp4, Sp1, or Sp3 with Crx would mutually up-or down-regulate their effects on transcription from the rod opsin promoter. Transient co-transfections of Sp4-, Sp1-, or Sp3-expression plasmid with the Crx expression plasmid were carried out together with the rod opsin/luc reporter construct (Fig. 3A) . The results showed that significant enhancement of transcriptional activation could be obtained upon co-expressing either Sp4-Crx (81-fold) or Sp1-Crx (66-fold) . Surprisingly, when we co-expressed Crx with Sp3, a synergistic enhancement of transcriptional activity was also observed (37-fold for the Crx/Sp3 combination compared with 6-fold with Crx alone and 2-fold for Sp3 alone). Mechanistically, such a synergistic effect could be explained by Sp3-Crx protein-protein interactions in combination with Crx-DNA and Sp3-DNA interactions that allow for stronger and/or additional recruitment of Crx at the rod opsin promoter and possibly certain other photoreceptor-specific promoters. These interactions increase the number of Crx activation domains anchored at the promoter with the assistance of Sp3, therefore enhancing the activity of a promoter containing both functional Crx-response element and Sp-recognition sequence. However, the activation potential of transcription factor pairs was as follows: Sp4-Crx Ͼ Sp1-Crx Ͼ Sp3-Crx emphasizing the important potential contributions of the activation domains of different Sp proteins in transcriptional activation of the rod opsin promoter. Other important functional differences relevant to the diverse synergistic effects of different Sp factors with Crx could lie in other parts of the molecules and most likely affect protein-protein interactions.
We have previously shown that Crx is unlikely to be a major functional activator of the ␤-PDE promoter in vivo despite the presence of a consensus Crx-response element and its potential for the promoter occupancy (22) . Thus, we used the ␤-PDE promoter/luc reporter construct as a control for promoter specificity of the Sp4-Crx synergistic effect in co-transfections with Sp4 and Crx. Although Crx overexpressed alone produced about 3-4-fold activation and Sp4 alone caused about 20 
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activation from this promoter (Fig. 3B) . In fact, we observed a mild inhibition of the Sp4-mediated ␤-PDE promoter activation (about 16-fold compared with 20-fold with Sp4 alone). These results could be explained by the close spatial proximity of the ␤/GC (Ϫ59/Ϫ49) and Crx-response element (Ϫ41/Ϫ36) sites on the ␤-PDE promoter. We propose the possibility that concomitant binding of the two proteins to this promoter region may result in a partial obstruction of the Sp4-DNA interaction and therefore, mild decrease in the Sp4-mediated transcriptional activation in the presence of high levels of overexpressed Crx.
Zinc Finger Domains of Sp4, Sp1, or Sp3 and Homedomain of Crx Are Necessary and Sufficient for Sp-Crx Interactions-To
evaluate the structural basis for the functional synergy observed between Sp4 and Crx, we tested whether Sp4 is able to bind Crx in solution in the absence of their respective DNAbinding sites and to determine their structural domain requirements for Sp4-Crx interactions, we performed co-immunoprecipitation experiments using isolated full-length proteins and their domain-deleted mutants. Initially, we performed co-immunoprecipitations with equal amounts of in vitro translated full-length 35 S-labeled Sp4 and unlabeled Crx. The mixture was precipitated with the anti-Crx antibody P261 and resolved by SDS-PAGE. We observed a positive interaction between full-length Sp4 and Crx (Fig. 4A, lane 1) , but not with the translation product from the empty pcDNA3.1/HisC vector used as control (lane 4). Next, we asked which region of Sp4 was necessary for its interactions with Crx. Co-immunoprecipitations were performed using two truncated forms of Sp4 containing either the zinc finger domain (Sp4ZnD) or a fingerless peptide (Sp4⌬DBD). Whereas the Sp4ZnD mutant was able to bind Crx (lane 2), no interaction was observed between Crx and the fingerless Sp4⌬DBD peptide under the same conditions (lane 3) or between Sp4ZnD and the product from the empty pcDNA3.1/HisC vector used as control (lane 5). Thus, the Sp4 zinc finger domain appears to be necessary and sufficient for direct Sp4-Crx interaction.
To verify the above results, we performed reciprocal co-immunoprecipitation assays using in vitro translated 35 S-labeled Crx with unlabeled Sp4. The mixture was immunoprecipitated with the anti-Sp4 antibody. Similar experiments were also performed using the 35 S-labeled N-terminal homeodomain-containing peptide (CrxHD) or the activation domain-containing C-terminal peptide lacking the homeodomain (Crx⌬HD). The immunoprecipitated products of these experiments were resolved by SDS-PAGE (Fig. 4B) . A positive interaction was observed with Sp4 and the full-length Crx (lane 1), consistent with our results using the anti-Crx antibody described above. An interaction between Sp4 and CrxHD was detected as well (lane 3). In contrast, no binding was seen between Sp4 and Crx⌬HD lacking the Crx homeodomain (lane 2). These results suggest that the Crx homeodomain is necessary and sufficient for mediating the Sp4-Crx interaction.
We then tested whether Sp1 would also directly bind Crx under the same assay conditions. Co-immunoprecipitation experiments were performed using equal amounts of in vitro translated full-length 35 S-labeled Sp1 and unlabeled Crx. The mixture was precipitated with the anti-Crx antibody P261 and resolved by SDS-PAGE. A positive interaction was observed between full-length Sp1 and Crx (Fig. 5A, lane 1 
), but not with the empty vector control (lane 2).
Because the zinc finger domains are highly conserved among Sp1, Sp3, and Sp4, we investigated whether Crx can also interact with the zinc finger domains of Sp1 and Sp3 using identical conditions as those for Sp4-Crx interaction. Co-immunoprecipitation experiments were performed using in vitro translated unlabeled full-length Crx and 35 S-labeled zinc fin- (2 g) was co-transfected in HEK293 cells with pcDNA-Crx (2 g) with or without 2 g of the expression plasmid encoding Sp1, Sp3, or Sp4, and the luciferase activity measured in cell lysates and normalized for each sample as described under "Experimental Procedures" was compared with that of the unstimulated Rho/luc reporter. B, to test for promoter specificity of the Sp4-Crx synergistic effect, the ␤-PDE promoter/luc reporter construct (2 g) was used in co-transfections with Sp4 and Crx. Although Crx moderately transactivates the ␤-PDE promoter when overexpressed at a high level, in co-transfection experiments we observed no synergistic effect between Sp4 and Crx on this promoter. The results are expressed as the -fold induction of the mean activity of the unstimulated Rho/luc or ␤-PDE/luc reporter construct, respectively Ϯ S.D. Each transfection was done in triplicate and repeated at least twice.
ger-containing peptides from Sp1 (Sp1ZnD), Sp3 (Sp3ZnD), or Sp4 (Sp4ZnD). The anti-Crx antibody was used for immunoprecipitation (Fig. 5B) . Positive interactions were observed between Crx and each of the Sp zinc finger domains tested (lanes 1-3), but not with the negative controls lacking the Crx protein (lanes 4 -6) . Lanes 7-9 show input controls for each of the zinc finger-containing peptides. Thus, Crx is able to bind three different members of the Sp family, Sp4, Sp1, and Sp3. The highly conserved zinc finger domains of the tested Sp proteins are sufficient for their interactions with Crx.
Sp4 and Crx Co-Occupy the Promoters of the Rod-specific opsin and ␤-PDE Genes in Vivo-To test the in vivo implications of the structural relationship observed between Sp4 and
Crx in the in vitro domain binding studies described above, we further investigated the possibility of Sp4-Crx interactions in vivo utilizing ChIP assays. Promoters of the rod-specific ␤-PDE and rod opsin genes that respond to Sp4-mediated activation in transient transfections were employed for the ChIP experiments. Both promoters, but not the liver-enriched albumin gene used as control, were present in the immunoprecipitated chromatin in the mouse retina using either anti-Crx or antiSp4 antibodies (Fig. 6A) . As additional controls, we showed that the retinal ChIP DNA was negative for amplicons of the 3Ј-flanking regions of both the rod opsin and ␤-PDE genes when either anti-Crx or anti-Sp4 antibodies were used (Fig.  6B) . These results indicate that Sp4 and Crx interactions with the target genes are promoter-specific. Isolation of DNAs corresponding to the promoter regions of rod-specific rod opsin and ␤-PDE genes by ChIP using either anti-Sp4 or anti-Crx antibodies strongly suggests the possibility of Sp4-Crx interactions in vivo.
To determine whether the occupancy of Sp4 and Crx on the rod opsin and ␤-PDE promoters is specific for retinal chromatin, we performed similar ChIP analysis using the non-retinal liver tissue. Neither gene promoter could be detected in the material precipitated with either anti-Sp4 or anti-Crx antibodies from liver (Fig. 6A ). This negative result is not because of the lack of Sp4 protein in liver, as PCR amplification of the immunoprecipitated liver chromatin using anti-Sp4 antibodies was positive for the albumin promoter. In addition, we previously showed that Sp4 is expressed in liver, although at a very low level compared with retina or brain (22) . Thus, the finding that Sp4 binds photoreceptor-specific gene promoters specifically in the context of retinal chromatin supports the role for Sp4 as a photoreceptor-enriched transcriptional regulator of these genes in vivo.
Sp4 Is Expressed at High Levels in Photoreceptors and Other
Retinal Neurons-The current data strongly suggest a role for Sp4 in transcriptional regulation of photoreceptor-enriched genes. However, if Sp4 regulates photoreceptor-specific gene transcription in vivo, we would expect it to be expressed at a relatively high level in retinal photoreceptors, and co-localize or overlap its pattern of expression with its proposed retinaenriched gene targets, as well as with its putative partner, Crx. We previously showed that Sp4 is present in retinal tissue by immunoblotting the crude nuclear extract from whole mouse retina (7) . To confirm our hypothesis, we tested the cellular Sp4 gene expression pattern in retina.
In situ hybridization analysis in the adult mouse retina showed that Sp4 mRNA was expressed at a relatively high level in the outer nuclear layer (ONL) that contains the nuclei of rod and cone photoreceptors, as well as in photoreceptor inner segments (Fig. 7, left panel) . However, Sp4 expression was not limited to the outer retina, as prominent staining was also detected within the inner nuclear layer (INL) and in ganglion cells. The laminar organization of retinal neurons into distinct layers containing particular cell types makes it possible to assign a tentative identity to retinal cells expressing Sp4. Thus, staining in the ONL and INL was strong and ubiquitous, presumably reflecting a high level of Sp4 expression in rod and cone photoreceptors, as well as in the retinal neurons that reside in the INL (i.e. bipolar, horizontal, amacrine cells, and Mü ller glia). An identical pattern of staining was observed with each of the three Sp4 riboprobes tested (see "Experimental Procedures"). The staining was completely absent in the control sections probed with Sp4 sense riboprobes (Fig. 7, right panel) .
To substantiate the in situ hybridization results on the protein level, the Sp4 spatial expression pattern was also tested by immunohistochemistry. Using the V-20 anti-Sp4 antibody that targets the Sp4 C terminus, intense staining was observed in all retinal layers spanning the entire thickness of each layer, which indicates that Sp4 is expressed in all retinal neurons (Fig. 8A) . We had previously shown that Sp4 is barely detectable in non-retinal tissues by immunoblotting (7) . In addition, staining was observed in all retinal layers when we tested the H-270 anti-Sp4 antibody directed against the N terminus of Sp4 (not shown). Staining was completely absent when primary anti-Sp4 antibody was omitted for the staining procedure (Fig. 8B) .
These results support our hypothesis that Sp4 is involved in transcriptional regulation of photoreceptor-specific genes such as rod opsin and ␤-PDE, and may interact with another photoreceptor-enriched transcriptional regulator, Crx, in photoreceptor cells and perhaps certain other retinal neurons given their overlapping expression patterns in the ONL and INL (12) .
DISCUSSION
Both Sp4 and Sp1 have been shown to bind the rod-specific ␤-PDE promoter, but only Sp4 has been observed to functionally transactivate this promoter when tested as single proteins both in vitro and in vivo (7, 22) . Thus, the first question we asked was whether the central nervous system-enriched Sp4 that we had found abundantly expressed in mammalian retina (7) is involved in transcriptional regulation of another important photoreceptor-restricted gene, rod opsin, rather than being a selective activator of the rod-specific ␤-PDE gene transcription. Our finding that Sp4 significantly activates transcription of both the rod opsin and ␤-PDE genes implies that indeed Sp4 is a more common regulator of photoreceptorspecific gene expression. As the molecular mechanisms of photoreceptor-specific transcriptional control are poorly understood, such a potential role for Sp4 is very intriguing.
Then, we hypothesized which other Sp4-related Sp family members may also be involved in transcriptional regulation of photoreceptor-specific genes because some of them, including Sp4, Sp1, and Sp3, have identical DNA-binding properties (17) . Sp3 showed no significant activation potential on either the rod opsin or ␤-PDE promoters, which is consistent with its known role as a transcriptional repressor. However, Sp1 showed an interesting pattern of substantial activation of the rod opsin promoter compared with its relatively insignificant effect on the ␤-PDE promoter. A possible explanation of such differential activation of transcription by Sp4 and Sp1 may be in that they differ in their functional interactions with other components of the transcription machinery on certain photoreceptor-specific promoters. It is conceivable that Sp4 is a more universal acti- were subjected to immunoprecipitation with the anti-Crx antibody P261. Co-immunoprecipitated proteins were analyzed by SDS-PAGE (11% gel) followed by autoradiography. Lane 3 shows in vitro translated Sp1 in the input material. B, zinc finger-containing 35 S-labeled peptides translated in vitro from the Sp1ZnD, Sp3ZnD, and Sp4ZnD plasmid constructs (see "Experimental Procedures"), respectively, in the presence of an unlabeled full-length Crx (lanes 1-3) or the translation product of its empty vector used as control (lanes 4 -6) were coimmunoprecipitated with the anti-Crx P261 antibody. Lanes 7-9 contain input controls showing each of the zinc finger-containing peptides. Various pairs of PCR primers designed to the promoter regions of the photoreceptor-specific rod opsin and ␤-PDE genes or the liver albumin gene were employed and yielded products of expected size. The input lanes show chromatin samples extracted from the retinal or liver tissue without the immunoprecipitation step. B, products of PCR amplification of DNA using primer pairs to the 3Ј-flanking regions of the rod opsin and ␤-PDE genes. Chromatin was isolated from the adult mouse retinas followed by ChIP using the same anti-Crx or anti-Sp4 antibody as in A. No antibody and mock (no chromatin) samples were included as controls.
vator of the photoreceptor-enriched transcriptional complex. This hypothesis is also supported by our further observations that either Sp1 or Sp3 co-expressed with Sp4 significantly inhibit Sp4-mediated transcriptional activation of the ␤-PDE promoter on which Sp1 and Sp3 showed no activation as single proteins (Fig. 2) . These results suggest that competition between Sp4 and a less potent Sp1 or Sp3 transcription factor for DNA binding at their common response element, ␤/GC (22), might be the molecular mechanism underlying such transcriptional repression. However, direct interactions between Sp4 and other nuclear proteins cannot be excluded as a mechanism of repression of the Sp4-activated transcription from the ␤-PDE promoter.
Thus, we hypothesized that there might be a component of the photoreceptor-specific transcription machinery that interacts directly with Sp4, but not with Sp1 or Sp3. An alternative hypothesis was that an additional transcriptional regulator interacts with both Sp4 and Sp1 to produce high levels of transcription, but only on certain promoters such as that of the rod opsin gene. To search for a potential protein target for Sp4 and possibly Sp1 in the photoreceptor-specific transcriptional apparatus, we examined the Sp proteins for their interactions with Crx, a known transcriptional activator involved in the regulation of multiple photoreceptor-specific genes including rod opsin (10) . To test this hypothesis, we asked whether there is functional evidence of Sp4-Crx interactions in living cells. Indeed, co-transfection experiments showed that Crx strongly synergizes with Sp4, but also shows some synergistic effect with Sp1 and Sp3 to activate transcription from the rod opsin promoter. To further test this unexpected finding, we examined the various Sp proteins for their structural interaction with Crx. We found that all of the Sp proteins tested (Sp4, Sp1, and Sp3) were able to bind Crx, and that their zinc finger domains were necessary and sufficient for binding the homeodomain of Crx using in vitro domain analysis in co-translation co-immunoprecipitation experiments. These protein-protein interactions were shown to take place in solution and any potential allosteric modulation of these interactions in the DNA-bound state is currently unknown. The finding that Crx directly interacts with the DNA-binding domains of different Sp proteins, and that all of these proteins synergize with Crx to a certain extent, suggest that this synergy is mediated at least partly at the level of protein-DNA binding rather than transcriptional regulation. Thus, the Crx-Sp protein interactions might regulate promoter activity by stabilizing the activator-DNA complex on the photoreceptorspecific promoters. However, because Sp4 and Sp1 produce much higher levels of transcriptional activation when co-transfected with Crx, they may additionally act by directly increasing the rate of transcriptional initiation by the general transcriptional apparatus through their activation domains. These data emphasize the potential importance of functional activation domains of Sp proteins for such synergistic activation of transcription.
The observation that both the rod opsin and ␤-PDE gene In situ hybridization analysis of Sp4 transcription in adult mouse retina. Left panel, high-level Sp4 mRNA expression is seen in the photoreceptor layer including the ONL and inner segments, as well as throughout the INL and ganglion cell layer using the KGH-2 Sp4 riboprobe; right panel, staining was completely absent in the retina when the sense Sp4 riboprobe was used as negative control. Sections were obtained through central retina. The cell layer labels are as follows: OS, outer segments; IS, inner segments; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. All pictures were taken at ϫ400 magnification. See "Experimental Procedures" for a complete list of probes used.
FIG. 8. Sp4 protein is highly expressed in photoreceptors and other retinal neurons.
Immunohistochemical localization (brown color) of Sp4 in adult mouse retina. A, Sp4 protein is highly expressed in all retinal nuclear layers. B, negative control for Sp4 immunohistochemistry with primary anti-Sp4 antibodies omitted from the staining procedure. Sections were cut through the central retina. The cell layer labels are as follows: OS, outer segments; IS, inner segments; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Sections were counterstained with hematoxylin to show nuclei (light blue). All pictures were taken at ϫ400 magnification.
promoters are direct targets of both Sp4 and Crx as we showed here using the ChIP approach provides strong evidence in support of in vivo interactions between Sp4 and Crx in the context of the retinal chromatin environment. It will be interesting to determine in future investigations whether Sp4 can bind its target DNA sequences cooperatively with Crx. It is not clear at present whether the part of Sp4 involved in Sp4-Crx interaction partially or completely overlaps with the Sp4 region required for its binding to DNA. Our co-transfection experiments showing synergistic activation of transcription between Crx and each of the Sp proteins tested (i.e. Sp4, Sp1, and Sp3) imply that putative multimerization regions of Sp proteins are available for protein-protein interactions in the DNA-bound state.
Another important observation is that when a luciferase reporter construct is co-transfected in HEK293 cells along with increasing amounts of the Sp4 expression plasmid, the promoter activity reaches a plateau and actually tends to decrease with higher quantities of transfected Sp4 expression vector (22) . This effect may be explained by a nonspecific inhibition of luciferase expression by abnormally high concentrations of Sp4 (or possibly its carrier plasmid) perhaps because of its nonspecific toxicity analogous to that previously reported for Sp1 (30) . Because the Sp1-mediated inhibition of reporter activity was previously observed using a chloramphenicol acetyltransferase gene for co-transfections in SL2 cells, one might suggest a general, nonspecific inhibition of transcription rather than a gene-specific or cell type-dependent mechanism. In addition, the transfection experiments carried out during this investigation were conducted in non-retinal HEK293 cells. Thus, physiological relevance of the results presented here remains to be confirmed in photoreceptor cells in vivo.
Cellular expression pattern of the Sp4 gene in photoreceptors of the ONL as well as in the retinal neurons of the INL and ganglion cell layer overlaps with that of Crx expressed in the photoreceptors and in the neurons of INL (12) . Such patterns of retinal localization supports our proposed role for Sp4 as a transcriptional regulator of various retina-specific and -enriched genes, and a potential partner for Crx given their overlapping expression patterns in retinal neurons of the ONL and INL.
In summary, our results support the involvement of Sp4 in the combinatorial regulation of rod-specific transcription of the ␤-PDE and rod opsin genes. These data also point out that a complex interplay between different members of the Sp family and their interactions with Crx are part of the transcriptional control mechanism on certain photoreceptor-specific promoters. As many of the genes encoding components of the phototransduction cascade are crucial for photoreceptor and retinal functional and structural integrity, the proposed role for Sp4 as a common transcriptional activator for some of these genes implies its potential importance in visual neuroscience in general and in retinal physiology and disease in particular.
